IntelliSpace Cardiovascular software versions 6.x, 7.x, and 8.x; Model Number: 830089.

FDA Device Recall #Z-1740-2025 - Class II, April 7, 2025

Recall Summary

Recall Number Z-1740-2025
Classification Class II - Moderate risk
Date Initiated April 7, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Philips Medical Systems Nederland B.V.
Location Eindhoven, N/A
Product Type Devices
Quantity 996 units (267 US, 729 OUS)

Product Description

IntelliSpace Cardiovascular software versions 6.x, 7.x, and 8.x; Model Number: 830089.

Reason for Recall

An issue was identified with the software when using the Echo Module of ISCV, the issue may result in missing or incomplete information in the report.

Distribution Pattern

Domestic: Nationwide Distribution International: Australia, Austria, Belgium, Canada, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Indonesia, Ireland, Italy, Japan, Luxembourg, Mexico, Netherlands, Norway, Poland, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Thailand, United Kingdom.

Lot / Code Information

Model Number: 830089; Software Versions: 6x, 7.x, and 8.x; UDI-DIs: (01)00884838106970(11)211130(10)6.1.0.0 (Version 6.1.0.0), (01)00884838106970(11)220623(10)6.2.0.0 (Version 6.2.0.0), (01)00884838115378(11)221214(10)7.0.0.0 (Version 7.0.0.0), (01)00884838115378(11)230711(10)7.1.0.0 (Version 7.1.0.0), (01)00884838122000(11)240325(10)8.0.0.0 (Version 8.0.0.0).

Other Recalls from Philips Medical Systems Nederland B.V.

Recall # Classification Product Date
Z-2932-2026 Class II Philips Azurion, Model Numbers: 722229, 722230... Jul 16, 2026
Z-2931-2026 Class II Philips Azurion Rystem, Model Numbers: 722063... Jul 16, 2026
Z-2928-2026 Class II Allura Xper FD. Model Numbers: 722026, 722027, ... Jun 29, 2026
Z-2893-2026 Class II Philips Allura, Cardio Vascular-Allura Centron.... Jun 17, 2026
Z-2892-2026 Class II Philips Azurion under the following System Desc... Jun 17, 2026

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.